This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

3D Printed Drugs Market

Penetration of Technological Advancements in Manufacturing Processes to widen prospects for 3D Printed Drugs

3D Printed Drugs Market By Dosage Form, Technology & Region - Forecast 2022 - 2032

3D Printed Drugs Market Snapshot (2022-2032)

[299 Pages Report] The global 3D printed drugs market is expected to garner a market value of US$ 307.54 Million in 2022 and is expected to accumulate a market value of US$ 742.88 Million by registering a CAGR of 9.2% in the forecast period 2022-2032. Growth of the 3D printed drugs market can be attributed to the increasing demand for customized drugs from different age groups. The market for 3D printed drugs registered a CAGR of 6.5% in the historical period 2016-2021.

Data Points

Key Statistics

Estimated Base Year Value (2021)

US$ 282.14 Million

Expected Market Value (2022)

US$ 307.54 Million

Anticipated Forecast Value (2032)

US$ 742.88 Million

Projected Growth Rate (2022-2032)

9.2% CAGR

3D printing was pioneered way back in 1986 but has recently begun to enter the public consciousness. Over the past ten years, it has blurred the boundaries between science fiction and fact. It is also known as Additive Manufacturing and is used in the automobile industry, aerospace & defence, retail and in the medical healthcare industry, amongst many others.

A major component of this is the 3D printed drugs market. 3D printing helps make what was once expensive and inaccessible much more cost-effective. Can this be more apt and necessary anywhere else than in the field of medicine? 3D printing is already used to print artificial bones, to create surgical materials with 3D scans to replace a damaged or missing bone and even to create hearing aid devices. Skull implants have been made for people with head injuries and even titanium heels to replace bone cancer afflicted patients.

Customize this Report

Let us know your requirement to get
100% FREE customization

2016-2021 3D Printed Drugs Demand Analysis vs. Forecast 2022-2032

The global demand for 3D printed drugs is projected to increase at a CAGR of 9.2% during the forecast period between 2022 and 2032, reaching a total of US$ 307.54 Million in 2032, according to a report from Future Market Insights (FMI). From 2016 to 2021, sales witnessed significant growth, registering a CAGR of 6.5%.

3D printed drugs are prominently being used in the healthcare sector since a long time. The use of 3D printing to produce drugs is not only helping the healthcare sector to grow at a rapid speed but also is helping in saving expenses. The COVID-19 pandemic accelerated the use of 3D printed drugs and affected the market positively.

As technological advancements are shaping the pharmaceutical industry, development of 3D printed drugs has accelerated at a humongous scale. Moreover, with more people being diagnosed with chronic diseases, the demand for 3D printed drugs is expected to increase.

Which are Some Prominent Drivers of 3D Printed Drugs Market?

There are several factors which help the 3D printed drugs sales to grow. One key advantage is their instantaneous solubility. 3D printed drugs are produced using powder bed inkjet printing. The elements of the drug are added in a layer-by-layer approach akin to 3D printing for any other device.

This makes the drugs easier to swallow and can be very helpful for patients suffering from dysphagia. 3D printing could also augment the arrival of individualized drugs or the creation of a combination of drugs. They could be customized for each patient, which would help much more than batch-produced drugs since they would be created specifically taking into account that patient’s medical history.

3D printed drugs could also make children far less resistant to taking the required medication, since they may be able to choose the shape, colour, design and even taste of the tablet! These are anticipated to be the main drivers of the 3D printed drug market.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

What are the Challenges Faced by the 3D Printed Drugs Market?

Any new technology adopted will inevitably have some downsides and it can sometimes be a race against time to anticipate and then mitigate them. With regards to the 3D printed drugs market, a 3D blueprint has to be made of the patient, their medical history, the dosage required etc.

With many scandals surrounding hacking and phishing of data stored online & on the cloud entering the mainstream consciousness, patients might be reluctant to disclose their medical information for 3D printed drugs. Another issue could be regarding mislabelling of blueprints, filling the wrong description or even having a higher dosage strength than advertised.

3D printing becoming commonplace could also be used to print illegal drugs, which will do little to help authorities stop the thriving black market trade for them. The main challenge for the 3D printed drugs market, however, would be a lack of regulation.

Most local, domestic and international regulatory bodies have no clear laws regarding 3D printing. There is a question concerning whom the liability will fall on should the drug lead to an adverse reaction – the 3D printing company, medicine Company, or the ingredients supplier.

Global nature of drugs is also another problem. Drug companies involved in the 3D printed drugs market would need to ensure that the right packaging and user instructions are accessible. It can also be a major issue printing drugs in a country which has no clear laws regarding its approval.

Region-Wise Insights

Research and Development Contributing to 3D Printed Drugs Market in Europe?

Development of pharmaceutical sector bolstering growth of 3D printed drugs

The dominant role played by pharmaceutical companies in the U.K. along with them having a strong domestic healthcare infrastructure is contributing to the growth of the 3D drug printed market.

Moreover, the pharmaceutical sector is highly dependent on research and development spending which also explains their reason for the growth of the market. Thus, due to the reasons mentioned above, Europe is expected to procure 29.9% market share as of 2022.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Chronic Diseases Inflcuening Growth of 3D Printed Drugs in North America?

Technological developments spurring growth of 3D printed drugs

Increasing incidences of chronic diseases especially in the geriatric population is accelerating the demand for 3D printed drugs in North America. In addition, the presence of excellent domestic healthcare infrastructure in U.S. and Canada are positively influencing the growth of 3D printed drugs.

Strong investment in research and development along with expanding use of technological developments is further bolstering the demand for 3D printed drugs in the North America region. Thus, owing to the aforementioned reasons, North America is expected to possess 31.1% for 3D printed drugs in 2022.

Clinical Development Frameworks Changing Landscape for 3D Printed Drugs in Asia Pacific?

Emerging economies creating lucrative opportunities for development of 3D printed drugs

Significant developments by China and Japan in the technological integration of 3D printed drug methodologies is driving the growth of the 3D printed drugs market in Asia Pacific. In addition, use of technology is shaping the 3D printed drugs market in the region.

Moreover, the development of healthcare infrastructure, R&D, and clinical development frameworks of emerging economies such as India and Australia have poised the Asia Pacific market to witness lucrative opportunities and growth throughout the forecast period. Thus, Asia Pacific is expected to hold 27% market share in 2022.

Category-Wise Insights

Growing Awareness of Inkjet Printer Technology Spurring growth of 3D Printed Drugs?

Technological superiorities easing the use of inkjet printers

Inkjet printing is a method of depositing three-dimensional shapes in solid dosage forms by spraying various combinations of active pharmaceutical ingredients and excipients (inks) through a nozzle. Inkjet technology generates 3D drugs at a steady rate and has technological superiorities over other techniques. Moreover, it has a high adoption rate among patients.

Furthermore, increased epilepsy incidences along with technological advancements in 3D printing technology, and expanding awareness of this technology in emerging nations are primary market growth drivers. Thus, inkjet printer technology is expected to hold 24% market share for 3D printed drugs in 2022.

Hospitals and Clinics Favouring Production of On-Demand Manufacturing of Medicines?

Easy installation and less wastage accelerating production of 3D printed medicines in hospitals and clinics

Growth of hospitals and clinics is driven by the growing demand for pharmaceuticals and cost-effective use of bio-drugs employing this technology. In addition, widespread use of prescription pills to treat a variety of chronic diseases is increasing the dependency on personalized pharmaceuticals.

Additionally, it can considerably save expenses, waste, and environmental strain. Furthermore, in hospitals and clinics, these printers can be installed to enable the on-demand manufacturing of medications, specifically those with poor stability or that need to be stored in a cold chain. Thus, hospitals and clinics are expected to possess 45% market share for 3D printed drugs market.

Start-Ups for 3D Printed Drugs Market

Key start-up players in the 3D printed drugs market are 3D LifePrints, BellaSeno, Multiply Labs, BioSpaein and AMSystems Center.

  • BellaSeno, a key player in the 3D printed drugs market is focusing on providing breasts scaffolds that are 3D printed with biocompatible absorbable polymers. This helps patients to recover from mastectomy.
  • AMSystems Center, another key player in the 3D printed drugs market is focusing on using 3D printing technology to manufacture medicines and use the same for other pharma applications such as bio-interfaces and drug-eluting capabilities.

Market Competition

Key players in the 3D printed drugs market are Hewlett Packard Caribe, Merck, Cycle Pharmaceuticals, AstraZeneca, Aprecia, Osmotica Pharmaceuticals, Aprecia Pharmaceuticals LLC Extend Biosciences, Bioduro, Affinity Therapeutics, GlaxoSmithKline Plc and FabRx Ltd

  • In September 2021, Cycle Pharmaceuticals has launched SAJAZIR injection. The injection can be used for hereditary angioedema. The company is focusing on producing therapeutic products by using 3D printed drug technology.
  • In April 2021, Aprecia Pharmaceuticals collaborated with Nanofarm to advance 3D printed nanomedicines. The company is focusing on providing customer and pharmaceutical industries with new capabilities in patient centric therapies.

Report Scope

Report Attribute

Details

Market Value in 2022

US$ 307.54 Million

Market Value in 2032

US$ 742.88 Million

Growth Rate

CAGR of 9.2% from 2022 to 2032

Base Year for Estimation

2021

Historical Data

2017-2021

Forecast Period

2022-2032

Quantitative Units

Revenue in USD Million and CAGR from 2022-2032

Report Coverage

Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis

Segments Covered

  • Dosage Form
  • Technology
  • Region

Regions Covered

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

Key Countries Profiled

  • U.S
  • Canada
  • Brazil
  • Mexico
  • Germany
  • U.K
  • France
  • Spain
  • Italy
  • China
  • Japan
  • South Korea
  • GCC
  • South Africa
  • Israel

Key Companies Profiled

  • Aprecia
  • FabRx Ltd.
  • Extend Biosciences
  • Bioduro
  • Affinity Therapeutics
  • Tvasta
  • Merck KGaA
  • Terumo Corporation
  • Cycle Pharmaceuticals
  • AstraZeneca
  • GlaxoSmithKline Plc.
  • Osmotica Pharmaceuticals

Customization

Available Upon Request

Key Segments Profiled in the 3D Printed Drugs Market Industry Survey

3D Printed Drugs Market by Dosage Form:

  • 3D Printed Tablets
  • 3D Printed Capsules
  • 3D Printed Multi Drug Implants
  • 3D Printed Nanoparticles
  • 3D Printed Solutions
  • Other 3D Printed Drug Dosage Forms

3D Printed Drugs Market by Technology:

  • Inkjet 3D Printed Drugs
  • Direct Write 3D Printed Drugs
  • Zip Dose 3D Printed Drugs
  • Thermal Inkjet 3D Printed Drugs
  • 3D Printed Drugs based on Fused Deposition Modeling
  • Powder Bed 3D Printed Drugs
  • Stereo Lithography (SLA) 3D Printed Drugs
  • Semi Solid Extrusion (SSE) 3D Printed Drugs

3D Printed Drugs Market by Region:

  • North America 3D Printed Drugs Market
  • Latin America 3D Printed Drugs Market
  • Europe 3D Printed Drugs Market
  • Asia Pacific 3D Printed Drugs Market
  • Middle East & Africa 3D Printed Drugs Market

Frequently Asked Questions

FMI projects the global 3D printed drugs market to expand at a 9.2% value CAGR by 2032

The global 3D printed drugs market is estimated at a market value of US$ 307.54 Million

The global 3D printed drugs market is expected to garner a market value of US$ 742.88 Million

North America is expected to possess 31.1% for 3D printed drugs in the assessment period 2022-2032

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global 3D Printed Drugs Market Analysis 2016-2021 and Forecast, 2022-2032

    4.1. Historical Market Size Value (US$ Mn) Analysis, 2016-2021

    4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global 3D Printed Drugs Market Analysis 2016-2021 and Forecast 2022-2032, By Dosage Form

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Mn) Analysis By Dosage Form, 2016-2021

    5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Dosage Form, 2022-2032

        5.3.1. Tablets

        5.3.2. Capsules

        5.3.3. Multi Drug Implants

        5.3.4. Nanoparticles

        5.3.5. Solutions

        5.3.6. Others

    5.4. Y-o-Y Growth Trend Analysis By Dosage Form, 2016-2021

    5.5. Absolute $ Opportunity Analysis By Dosage Form, 2022-2032

6. Global 3D Printed Drugs Market Analysis 2016-2021 and Forecast 2022-2032, By Technology

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Mn) Analysis By Technology, 2016-2021

    6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Technology, 2022-2032

        6.3.1. Inkjet Printing

        6.3.2. Direct Write

        6.3.3. Zip Dose

        6.3.4. Thermal Inkjet Printing

        6.3.5. Fused Deposition Modelling

        6.3.6. Powder Bed Printing

        6.3.7. Stereo Lithography (SLA)

        6.3.8. Semi Solid Extrusion (SSE)

    6.4. Y-o-Y Growth Trend Analysis By Technology, 2016-2021

    6.5. Absolute $ Opportunity Analysis By Technology, 2022-2032

7. Global 3D Printed Drugs Market Analysis 2016-2021 and Forecast 2022-2032, By Region

    7.1. Introduction

    7.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2016-2021

    7.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032

        7.3.1. North America

        7.3.2. Latin America

        7.3.3. Europe

        7.3.4. Asia Pacific

        7.3.5. MEA

    7.4. Market Attractiveness Analysis By Region

8. North America 3D Printed Drugs Market Analysis 2016-2021 and Forecast 2022-2032, By Country

    8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021

    8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        8.2.1. By Country

            8.2.1.1. US

            8.2.1.2. Canada

        8.2.2. By Dosage Form

        8.2.3. By Technology

    8.3. Market Attractiveness Analysis

        8.3.1. By Country

        8.3.2. By Dosage Form

        8.3.3. By Technology

    8.4. Key Takeaways

9. Latin America 3D Printed Drugs Market Analysis 2016-2021 and Forecast 2022-2032, By Country

    9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021

    9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        9.2.1. By Country

            9.2.1.1. Brazil

            9.2.1.2. Mexico

            9.2.1.3. Rest of Latin America

        9.2.2. By Dosage Form

        9.2.3. By Technology

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Dosage Form

        9.3.3. By Technology

    9.4. Key Takeaways

10. Europe 3D Printed Drugs Market Analysis 2016-2021 and Forecast 2022-2032, By Country

    10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021

    10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        10.2.1. By Country

            10.2.1.1. Germany

            10.2.1.2. U.K.

            10.2.1.3. France

            10.2.1.4. Spain

            10.2.1.5. Italy

            10.2.1.6. Rest of Europe

        10.2.2. By Dosage Form

        10.2.3. By Technology

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Dosage Form

        10.3.3. By Technology

    10.4. Key Takeaways

11. Asia Pacific 3D Printed Drugs Market Analysis 2016-2021 and Forecast 2022-2032, By Country

    11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021

    11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        11.2.1. By Country

            11.2.1.1. China

            11.2.1.2. Japan

            11.2.1.3. South Korea

            11.2.1.4. Rest of Asia Pacific

        11.2.2. By Dosage Form

        11.2.3. By Technology

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Dosage Form

        11.3.3. By Technology

    11.4. Key Takeaways

12. MEA 3D Printed Drugs Market Analysis 2016-2021 and Forecast 2022-2032, By Country

    12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021

    12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        12.2.1. By Country

            12.2.1.1. GCC Countries

            12.2.1.2. South Africa

            12.2.1.3. Israel

            12.2.1.4. Rest of MEA

        12.2.2. By Dosage Form

        12.2.3. By Technology

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Dosage Form

        12.3.3. By Technology

    12.4. Key Takeaways

13. Key Countries 3D Printed Drugs Market Analysis

    13.1. US

        13.1.1. Pricing Analysis

        13.1.2. Market Share Analysis, 2021

            13.1.2.1. By Dosage Form

            13.1.2.2. By Technology

    13.2. Canada

        13.2.1. Pricing Analysis

        13.2.2. Market Share Analysis, 2021

            13.2.2.1. By Dosage Form

            13.2.2.2. By Technology

    13.3. Brazil

        13.3.1. Pricing Analysis

        13.3.2. Market Share Analysis, 2021

            13.3.2.1. By Dosage Form

            13.3.2.2. By Technology

    13.4. Mexico

        13.4.1. Pricing Analysis

        13.4.2. Market Share Analysis, 2021

            13.4.2.1. By Dosage Form

            13.4.2.2. By Technology

    13.5. Germany

        13.5.1. Pricing Analysis

        13.5.2. Market Share Analysis, 2021

            13.5.2.1. By Dosage Form

            13.5.2.2. By Technology

    13.6. U.K.

        13.6.1. Pricing Analysis

        13.6.2. Market Share Analysis, 2021

            13.6.2.1. By Dosage Form

            13.6.2.2. By Technology

    13.7. France

        13.7.1. Pricing Analysis

        13.7.2. Market Share Analysis, 2021

            13.7.2.1. By Dosage Form

            13.7.2.2. By Technology

    13.8. Spain

        13.8.1. Pricing Analysis

        13.8.2. Market Share Analysis, 2021

            13.8.2.1. By Dosage Form

            13.8.2.2. By Technology

    13.9. Italy

        13.9.1. Pricing Analysis

        13.9.2. Market Share Analysis, 2021

            13.9.2.1. By Dosage Form

            13.9.2.2. By Technology

    13.10. China

        13.10.1. Pricing Analysis

        13.10.2. Market Share Analysis, 2021

            13.10.2.1. By Dosage Form

            13.10.2.2. By Technology

    13.11. Japan

        13.11.1. Pricing Analysis

        13.11.2. Market Share Analysis, 2021

            13.11.2.1. By Dosage Form

            13.11.2.2. By Technology

    13.12. South Korea

        13.12.1. Pricing Analysis

        13.12.2. Market Share Analysis, 2021

            13.12.2.1. By Dosage Form

            13.12.2.2. By Technology

    13.13. GCC Countries

        13.13.1. Pricing Analysis

        13.13.2. Market Share Analysis, 2021

            13.13.2.1. By Dosage Form

            13.13.2.2. By Technology

    13.14. South Africa

        13.14.1. Pricing Analysis

        13.14.2. Market Share Analysis, 2021

            13.14.2.1. By Dosage Form

            13.14.2.2. By Technology

    13.15. Israel

        13.15.1. Pricing Analysis

        13.15.2. Market Share Analysis, 2021

            13.15.2.1. By Dosage Form

            13.15.2.2. By Technology

14. Market Structure Analysis

    14.1. Competition Dashboard

    14.2. Competition Benchmarking

    14.3. Market Share Analysis of Top Players

        14.3.1. By Regional

        14.3.2. By Dosage Form

        14.3.3. By Technology

15. Competition Analysis

    15.1. Competition Deep Dive

        15.1.1. Aprecia

            15.1.1.1. Overview

            15.1.1.2. Product Portfolio

            15.1.1.3. Profitability by Market Segments

            15.1.1.4. Sales Footprint

            15.1.1.5. Strategy Overview

                15.1.1.5.1. Marketing Strategy

        15.1.2. FabRx LTD

            15.1.2.1. Overview

            15.1.2.2. Product Portfolio

            15.1.2.3. Profitability by Market Segments

            15.1.2.4. Sales Footprint

            15.1.2.5. Strategy Overview

                15.1.2.5.1. Marketing Strategy

        15.1.3. Extend Biosciences

            15.1.3.1. Overview

            15.1.3.2. Product Portfolio

            15.1.3.3. Profitability by Market Segments

            15.1.3.4. Sales Footprint

            15.1.3.5. Strategy Overview

                15.1.3.5.1. Marketing Strategy

        15.1.4. Bioduro

            15.1.4.1. Overview

            15.1.4.2. Product Portfolio

            15.1.4.3. Profitability by Market Segments

            15.1.4.4. Sales Footprint

            15.1.4.5. Strategy Overview

                15.1.4.5.1. Marketing Strategy

        15.1.5. Affinity Therapeutics

            15.1.5.1. Overview

            15.1.5.2. Product Portfolio

            15.1.5.3. Profitability by Market Segments

            15.1.5.4. Sales Footprint

            15.1.5.5. Strategy Overview

                15.1.5.5.1. Marketing Strategy

        15.1.6. Tvasta

            15.1.6.1. Overview

            15.1.6.2. Product Portfolio

            15.1.6.3. Profitability by Market Segments

            15.1.6.4. Sales Footprint

            15.1.6.5. Strategy Overview

                15.1.6.5.1. Marketing Strategy

        15.1.7. Merck KGaA

            15.1.7.1. Overview

            15.1.7.2. Product Portfolio

            15.1.7.3. Profitability by Market Segments

            15.1.7.4. Sales Footprint

            15.1.7.5. Strategy Overview

                15.1.7.5.1. Marketing Strategy

        15.1.8. Terumo Corporation

            15.1.8.1. Overview

            15.1.8.2. Product Portfolio

            15.1.8.3. Profitability by Market Segments

            15.1.8.4. Sales Footprint

            15.1.8.5. Strategy Overview

                15.1.8.5.1. Marketing Strategy

        15.1.9. Cycle Pharmaceuticals

            15.1.9.1. Overview

            15.1.9.2. Product Portfolio

            15.1.9.3. Profitability by Market Segments

            15.1.9.4. Sales Footprint

            15.1.9.5. Strategy Overview

                15.1.9.5.1. Marketing Strategy

        15.1.10. AstraZeneca

            15.1.10.1. Overview

            15.1.10.2. Product Portfolio

            15.1.10.3. Profitability by Market Segments

            15.1.10.4. Sales Footprint

            15.1.10.5. Strategy Overview

                15.1.10.5.1. Marketing Strategy

        15.1.11. GlaxoSmithKline Plc

            15.1.11.1. Overview

            15.1.11.2. Product Portfolio

            15.1.11.3. Profitability by Market Segments

            15.1.11.4. Sales Footprint

            15.1.11.5. Strategy Overview

                15.1.11.5.1. Marketing Strategy

        15.1.12. Osmotica Pharmaceuticals

            15.1.12.1. Overview

            15.1.12.2. Product Portfolio

            15.1.12.3. Profitability by Market Segments

            15.1.12.4. Sales Footprint

            15.1.12.5. Strategy Overview

                15.1.12.5.1. Marketing Strategy

16. Assumptions & Acronyms Used

17. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global 3D Printed Drugs Market Value (US$ Mn) Forecast by Region, 2016-2032

Table 2: Global 3D Printed Drugs Market Value (US$ Mn) Forecast by Dosage Form, 2016-2032

Table 3: Global 3D Printed Drugs Market Value (US$ Mn) Forecast by Technology, 2016-2032

Table 4: North America 3D Printed Drugs Market Value (US$ Mn) Forecast by Country, 2016-2032

Table 5: North America 3D Printed Drugs Market Value (US$ Mn) Forecast by Dosage Form, 2016-2032

Table 6: North America 3D Printed Drugs Market Value (US$ Mn) Forecast by Technology, 2016-2032

Table 7: Latin America 3D Printed Drugs Market Value (US$ Mn) Forecast by Country, 2016-2032

Table 8: Latin America 3D Printed Drugs Market Value (US$ Mn) Forecast by Dosage Form, 2016-2032

Table 9: Latin America 3D Printed Drugs Market Value (US$ Mn) Forecast by Technology, 2016-2032

Table 10: Europe 3D Printed Drugs Market Value (US$ Mn) Forecast by Country, 2016-2032

Table 11: Europe 3D Printed Drugs Market Value (US$ Mn) Forecast by Dosage Form, 2016-2032

Table 12: Europe 3D Printed Drugs Market Value (US$ Mn) Forecast by Technology, 2016-2032

Table 13: Asia Pacific 3D Printed Drugs Market Value (US$ Mn) Forecast by Country, 2016-2032

Table 14: Asia Pacific 3D Printed Drugs Market Value (US$ Mn) Forecast by Dosage Form, 2016-2032

Table 15: Asia Pacific 3D Printed Drugs Market Value (US$ Mn) Forecast by Technology, 2016-2032

Table 16: MEA 3D Printed Drugs Market Value (US$ Mn) Forecast by Country, 2016-2032

Table 17: MEA 3D Printed Drugs Market Value (US$ Mn) Forecast by Dosage Form, 2016-2032

Table 18: MEA 3D Printed Drugs Market Value (US$ Mn) Forecast by Technology, 2016-2032

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 1: Global 3D Printed Drugs Market Value (US$ Mn) by Dosage Form, 2022-2032

Figure 2: Global 3D Printed Drugs Market Value (US$ Mn) by Technology, 2022-2032

Figure 3: Global 3D Printed Drugs Market Value (US$ Mn) by Region, 2022-2032

Figure 4: Global 3D Printed Drugs Market Value (US$ Mn) Analysis by Region, 2016-2032

Figure 5: Global 3D Printed Drugs Market Value Share (%) and BPS Analysis by Region, 2022-2032

Figure 6: Global 3D Printed Drugs Market Y-o-Y Growth (%) Projections by Region, 2022-2032

Figure 7: Global 3D Printed Drugs Market Value (US$ Mn) Analysis by Dosage Form, 2016-2032

Figure 8: Global 3D Printed Drugs Market Value Share (%) and BPS Analysis by Dosage Form, 2022-2032

Figure 9: Global 3D Printed Drugs Market Y-o-Y Growth (%) Projections by Dosage Form, 2022-2032

Figure 10: Global 3D Printed Drugs Market Value (US$ Mn) Analysis by Technology, 2016-2032

Figure 11: Global 3D Printed Drugs Market Value Share (%) and BPS Analysis by Technology, 2022-2032

Figure 12: Global 3D Printed Drugs Market Y-o-Y Growth (%) Projections by Technology, 2022-2032

Figure 13: Global 3D Printed Drugs Market Attractiveness by Dosage Form, 2022-2032

Figure 14: Global 3D Printed Drugs Market Attractiveness by Technology, 2022-2032

Figure 15: Global 3D Printed Drugs Market Attractiveness by Region, 2022-2032

Figure 16: North America 3D Printed Drugs Market Value (US$ Mn) by Dosage Form, 2022-2032

Figure 17: North America 3D Printed Drugs Market Value (US$ Mn) by Technology, 2022-2032

Figure 18: North America 3D Printed Drugs Market Value (US$ Mn) by Country, 2022-2032

Figure 19: North America 3D Printed Drugs Market Value (US$ Mn) Analysis by Country, 2016-2032

Figure 20: North America 3D Printed Drugs Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 21: North America 3D Printed Drugs Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 22: North America 3D Printed Drugs Market Value (US$ Mn) Analysis by Dosage Form, 2016-2032

Figure 23: North America 3D Printed Drugs Market Value Share (%) and BPS Analysis by Dosage Form, 2022-2032

Figure 24: North America 3D Printed Drugs Market Y-o-Y Growth (%) Projections by Dosage Form, 2022-2032

Figure 25: North America 3D Printed Drugs Market Value (US$ Mn) Analysis by Technology, 2016-2032

Figure 26: North America 3D Printed Drugs Market Value Share (%) and BPS Analysis by Technology, 2022-2032

Figure 27: North America 3D Printed Drugs Market Y-o-Y Growth (%) Projections by Technology, 2022-2032

Figure 28: North America 3D Printed Drugs Market Attractiveness by Dosage Form, 2022-2032

Figure 29: North America 3D Printed Drugs Market Attractiveness by Technology, 2022-2032

Figure 30: North America 3D Printed Drugs Market Attractiveness by Country, 2022-2032

Figure 31: Latin America 3D Printed Drugs Market Value (US$ Mn) by Dosage Form, 2022-2032

Figure 32: Latin America 3D Printed Drugs Market Value (US$ Mn) by Technology, 2022-2032

Figure 33: Latin America 3D Printed Drugs Market Value (US$ Mn) by Country, 2022-2032

Figure 34: Latin America 3D Printed Drugs Market Value (US$ Mn) Analysis by Country, 2016-2032

Figure 35: Latin America 3D Printed Drugs Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 36: Latin America 3D Printed Drugs Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 37: Latin America 3D Printed Drugs Market Value (US$ Mn) Analysis by Dosage Form, 2016-2032

Figure 38: Latin America 3D Printed Drugs Market Value Share (%) and BPS Analysis by Dosage Form, 2022-2032

Figure 39: Latin America 3D Printed Drugs Market Y-o-Y Growth (%) Projections by Dosage Form, 2022-2032

Figure 40: Latin America 3D Printed Drugs Market Value (US$ Mn) Analysis by Technology, 2016-2032

Figure 41: Latin America 3D Printed Drugs Market Value Share (%) and BPS Analysis by Technology, 2022-2032

Figure 42: Latin America 3D Printed Drugs Market Y-o-Y Growth (%) Projections by Technology, 2022-2032

Figure 43: Latin America 3D Printed Drugs Market Attractiveness by Dosage Form, 2022-2032

Figure 44: Latin America 3D Printed Drugs Market Attractiveness by Technology, 2022-2032

Figure 45: Latin America 3D Printed Drugs Market Attractiveness by Country, 2022-2032

Figure 46: Europe 3D Printed Drugs Market Value (US$ Mn) by Dosage Form, 2022-2032

Figure 47: Europe 3D Printed Drugs Market Value (US$ Mn) by Technology, 2022-2032

Figure 48: Europe 3D Printed Drugs Market Value (US$ Mn) by Country, 2022-2032

Figure 49: Europe 3D Printed Drugs Market Value (US$ Mn) Analysis by Country, 2016-2032

Figure 50: Europe 3D Printed Drugs Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 51: Europe 3D Printed Drugs Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 52: Europe 3D Printed Drugs Market Value (US$ Mn) Analysis by Dosage Form, 2016-2032

Figure 53: Europe 3D Printed Drugs Market Value Share (%) and BPS Analysis by Dosage Form, 2022-2032

Figure 54: Europe 3D Printed Drugs Market Y-o-Y Growth (%) Projections by Dosage Form, 2022-2032

Figure 55: Europe 3D Printed Drugs Market Value (US$ Mn) Analysis by Technology, 2016-2032

Figure 56: Europe 3D Printed Drugs Market Value Share (%) and BPS Analysis by Technology, 2022-2032

Figure 57: Europe 3D Printed Drugs Market Y-o-Y Growth (%) Projections by Technology, 2022-2032

Figure 58: Europe 3D Printed Drugs Market Attractiveness by Dosage Form, 2022-2032

Figure 59: Europe 3D Printed Drugs Market Attractiveness by Technology, 2022-2032

Figure 60: Europe 3D Printed Drugs Market Attractiveness by Country, 2022-2032

Figure 61: Asia Pacific 3D Printed Drugs Market Value (US$ Mn) by Dosage Form, 2022-2032

Figure 62: Asia Pacific 3D Printed Drugs Market Value (US$ Mn) by Technology, 2022-2032

Figure 63: Asia Pacific 3D Printed Drugs Market Value (US$ Mn) by Country, 2022-2032

Figure 64: Asia Pacific 3D Printed Drugs Market Value (US$ Mn) Analysis by Country, 2016-2032

Figure 65: Asia Pacific 3D Printed Drugs Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 66: Asia Pacific 3D Printed Drugs Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 67: Asia Pacific 3D Printed Drugs Market Value (US$ Mn) Analysis by Dosage Form, 2016-2032

Figure 68: Asia Pacific 3D Printed Drugs Market Value Share (%) and BPS Analysis by Dosage Form, 2022-2032

Figure 69: Asia Pacific 3D Printed Drugs Market Y-o-Y Growth (%) Projections by Dosage Form, 2022-2032

Figure 70: Asia Pacific 3D Printed Drugs Market Value (US$ Mn) Analysis by Technology, 2016-2032

Figure 71: Asia Pacific 3D Printed Drugs Market Value Share (%) and BPS Analysis by Technology, 2022-2032

Figure 72: Asia Pacific 3D Printed Drugs Market Y-o-Y Growth (%) Projections by Technology, 2022-2032

Figure 73: Asia Pacific 3D Printed Drugs Market Attractiveness by Dosage Form, 2022-2032

Figure 74: Asia Pacific 3D Printed Drugs Market Attractiveness by Technology, 2022-2032

Figure 75: Asia Pacific 3D Printed Drugs Market Attractiveness by Country, 2022-2032

Figure 76: MEA 3D Printed Drugs Market Value (US$ Mn) by Dosage Form, 2022-2032

Figure 77: MEA 3D Printed Drugs Market Value (US$ Mn) by Technology, 2022-2032

Figure 78: MEA 3D Printed Drugs Market Value (US$ Mn) by Country, 2022-2032

Figure 79: MEA 3D Printed Drugs Market Value (US$ Mn) Analysis by Country, 2016-2032

Figure 80: MEA 3D Printed Drugs Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 81: MEA 3D Printed Drugs Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 82: MEA 3D Printed Drugs Market Value (US$ Mn) Analysis by Dosage Form, 2016-2032

Figure 83: MEA 3D Printed Drugs Market Value Share (%) and BPS Analysis by Dosage Form, 2022-2032

Figure 84: MEA 3D Printed Drugs Market Y-o-Y Growth (%) Projections by Dosage Form, 2022-2032

Figure 85: MEA 3D Printed Drugs Market Value (US$ Mn) Analysis by Technology, 2016-2032

Figure 86: MEA 3D Printed Drugs Market Value Share (%) and BPS Analysis by Technology, 2022-2032

Figure 87: MEA 3D Printed Drugs Market Y-o-Y Growth (%) Projections by Technology, 2022-2032

Figure 88: MEA 3D Printed Drugs Market Attractiveness by Dosage Form, 2022-2032

Figure 89: MEA 3D Printed Drugs Market Attractiveness by Technology, 2022-2032

Figure 90: MEA 3D Printed Drugs Market Attractiveness by Country, 2022-2032

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

3D-Printed Maxillofacial Implants Market

Published : November 2017

Technology

3D Printing Dental Device Market

Published : December 2016

Technology

3D Printed Hip And Knee Implants Market

Published : December 2016

Technology

3D Printing Market

Published : May 2021

Google translate

3D Printed Drugs Market